- Home
- ICON vs KTTA Comparison
ICON vs KTTA Comparison
Compare ICON & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ICON | KTTA |
|---|---|---|
| Founded | 2023 | 2020 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7M | 5.3M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ICON | KTTA |
|---|---|---|
| Price | $0.66 | $1.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $4.50 | $3.00 |
| AVG Volume (30 Days) | 146.8K | ★ 1.3M |
| Earning Date | 04-02-2026 | 11-13-2025 |
| Dividend Yield | ★ 1363.31% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,449,000.00 | N/A |
| Revenue This Year | $128.63 | N/A |
| Revenue Next Year | $10.92 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 96.44 | N/A |
| 52 Week Low | $0.55 | $0.28 |
| 52 Week High | $93.19 | $3.85 |
Technical Indicators
Market Signals| Indicator | ICON | KTTA |
|---|---|---|
| Relative Strength Index (RSI) | 35.92 | 57.97 |
| Support Level | $0.55 | $1.09 |
| Resistance Level | $0.77 | $1.21 |
| Average True Range (ATR) | 0.06 | 0.08 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 39.29 | 45.24 |
Price Performance
Historical ComparisonAbout ICON Icon Energy Corp.
Icon Energy Corp is a growth-oriented shipping company providing seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels. The company generates its revenues by chartering its vessels to regional and international dry bulk operators, commodity traders and end users.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).